0% Complete
the 4th international edition and 13th Iranian Conference on Bioinformatics
international edition and Iranian Conference on Bioinformatics
صفحه اصلی
/
4th international edition and 13th Iranian Conference on Bioinformatics
AI-Driven Discovery of Novel AChE Inhibitors for Alzheimer's Disease Treatment: Model Development, Molecular Docking, and MD Simulation
نویسندگان :
Ahmad Ebadi
1
Fatemeh Noori
2
1- دانشگاه علوم پزشکی همدان
2- دانشگاه علوم پزشکی همدان
کلمات کلیدی :
AI-assisted drug discovery،LSTM،Acetylcholinesterase inhibitors،Alzheimer’s disease،MD simulation
چکیده :
Background and Objective Alzheimer's disease (AD) is a progressive neurological disorder that primarily affects memory, thinking, and behavior (Stopschinski and Diamond, 2017). Acetylcholinesterase (AChE) is an essential enzyme in the nervous system responsible for breaking down acetylcholine, a neurotransmitter involved in transmitting signals between nerve cells (Chaves, Calheiro, 2020). In Alzheimer's, reduced levels of acetylcholine are linked to cognitive decline (Aktaş, Taslimi, Gülçin, Gök, 2017). The main goal of this study is to design a chemical language model (CLM) capable of generating novel AChE inhibitors that can effectively bind to AChE. Method & material A dataset of 613 known AChE inhibitors was compiled from the PubChem and ChemBL databases. The SMILES strings were tokenized into their constituent atomic and bonding elements. Data augmentation was employed to broaden the dataset, enabling the generation of a more diverse range of potential candidates. Here, 5 stages of data augmentation (0, 1, 3, 9, 19) were used. To convert each token into a dense vector representation, a 100-dimensional embedding layer was employed. The model architecture consisted of two LSTM layers, with 512 and 256 units, respectively. Training was carried out over 100 epochs. Libraries of compounds were then generated from the trained model at five distinct temperatures (0.2, 0.4, 0.6, 0.8, and 1), with each temperature yielding a unique set of compounds. A new library of novel and unique compounds was curated, and the highest-performing output was selected. Molecular docking and MD simulation were used to evaluate the generated compounds. MD simulations help to depict the long-range interactions, conformational changes, and flexibility of the inhibitor and protein. Findings The results obtained from this modeling were as follows: The model was trained using 9-fold data augmentation, resulting in more novel compounds at a temperature of 0.8. Overall, the model performed superbly in terms of considering compound novelty. At lower temperatures (0.2, 0.4), the model acted more conservatively, and generated more similar molecules. On the other hand, at higher temperatures (0.6, 0.8, 1.0), the model generated more diverse and novel molecules, possibly with new scaffolds or unconventional functional groups. The docking analysis demonstrated that the newly designed ligands, established crucial interactions with key tryptophan residues at positions 286 and 86. Additionally, the complex predicted by docking exhibited remarkable stability during a 100 ns molecular dynamics simulation. Conclusion The artificial intelligence model successfully learned the pharmacophore of AChE inhibitors from SMILES strings. After training, the model was able to generate novel inhibitors that retained the key pharmacophore features of the original compounds. Docking and molecular dynamics (MD) simulations further demonstrated that the predicted inhibitors effectively interact with crucial amino acid residues within the enzyme's active site.
لیست مقالات
لیست مقالات بایگانی شده
Computational Screening of Signal Peptides for Optimized Secretory Production of Recombinant Lutheran b (Lub) Blood Group Antigen in Human Cell Lines
Kosar Asadi - Maryam Latifi - Mansoureh Shahbazi Dastjerdeh
Investigating the Potential of Natural Small Molecules as BDNF Mimetics for Neurodegenerative Disease Treatment: A Molecular Docking Study with TrkB Receptor
Sevil Babashpour - Dina Morshedi - Farhang Aliakbari
Bioinformatic analysis of the role of S100A9 inhibition on reducing the brain metastasis in EGFR-mutant lung cancer
Homa Mollaei
Leveraging Machine Learning Models for Virtual Screening of ZINC Database to Identify JAK1 Inhibitors
Negar Abdolmaleki - Hamid Mahdiuni
Uncovering Disrupted Cell-Cell Interactions in Alzheimer's Disease Using Variational Graph Autoencoders on Single-Cell Spatial Transcriptomics Data from the Human Middle Temporal Gyrus
Zahra Bayat - Alireza Fotuhi Siahpirani
A Fuzzy Bayesian Network Model for Personalized Diabetes Risk Prediction: Integrating Lifestyle, Genetic, and Environmental Factors
Lida Hooshyar - Nadia Tahiri
AI-Driven Discovery of Novel AChE Inhibitors for Alzheimer's Disease Treatment: Model Development, Molecular Docking, and MD Simulation
Ahmad Ebadi - Fatemeh Noori
Computational Analysis of the D92V Mutation in the EF-hand II Loop of the Mnemiopsin 2 Photoprotein
Hanieh Ramezani - Vahab Jafarian - Akram Shirdel - Khosrow Khalifeh - Fatemeh Khatami
Common genes and pathways involved in prediabetes and diabetes using bioinformatics analysis
Ali reza Morovat - Kiarash Zare - Matin Sepehrinia - Mohammad mehdi Naghizadeh
Aureolysin Inhibition: Identification of Sigmoidin B as a Potential Therapeutic Candidate against Staphylococcus aureus
Amir Mohammad Akbarian Khujin - Melika Sadat Samadi - Ghazal Shirdel - Elnaz Afshari
بیشتر
ثمین همایش، سامانه مدیریت کنفرانس ها و جشنواره ها - نگارش 44.5.0